Medical methods for first-trimester abortion.
Nothnagle
Melissa
M
Brown Medical School, Providence, Rhode Island, USA. Melissa_nothnagle@mhri.org
Taylor
Julie Scott
JS
D000019:Abortifacient Agents / Q000627:therapeutic use*; D000028:Abortion, Induced / Q000379:methods*; D000527:Alprostadil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D015735:Mifepristone / Q000627:therapeutic use; D016595:Misoprostol / Q000627:therapeutic use; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
D000019:Abortifacient Agents; D011453:Prostaglandins; D013629:Tamoxifen; D016595:Misoprostol; D015735:Mifepristone; C021182:gemeprost; D000527:Alprostadil; D008727:Methotrexate